310 research outputs found

    A preliminary assessment of the Normative Framework regulating MAR schemes in Europe: the EU Directives and their Implementation in nine National Legislations

    Get PDF
    The use of MAR schemes within the European Union is not a new phenomenon, on the contrary it dates back to the beginning of the XIX century. Despite being widely adopted and currently the object of extensive studies, this tool is not soundly regulated and so far very little research has been conducted on the normative framework regulating MAR at the regional and at the national level. This paper draws upon the findings of a Report which represents one of the deliverables identified by MARSOL, a EU FP7 project launched in December 2013 that aims at demonstrating that MAR shall be regarded as a viable approach to address the predicted water shortages over the long term. Through a survey which involved a number of national experts, the researchers involved in the drafting of the Report have collected relevant data concerning the national legal frameworks of nine EU countries that adopt MAR schemes. The results of the questionnaire have been processed using a qualitative and comparative approach and have been duly included in the legal analysis, which covers the implementation at the national level of the two EU Directives relevant for MAR Schemes, i.e. the Water Framework Directive and its "daughter", the Groundwater Directive. This paper shall be considered as the outcome of a preliminary investigation which covered only a limited number of European countries, it is expected that the research will be carried out as to include a larger number of EU Member States (MSs), alongside the most relevant extra EU countries

    An open-label, one-arm, dose-escalation study to evaluate safety and tolerability of extremely low frequency magnetic fields in acute ischemic stroke

    Get PDF
    Extremely low frequency magnetic fields (ELF-MF) could be an alternative neuroprotective approach for ischemic stroke because preclinical studies have demonstrated their effects on the mechanisms underlying ischemic damage. The purpose of this open-label, one arm, dose-escalation, exploratory study is to evaluate the safety and tolerability of ELF-MF in patients with acute ischemic stroke. Within 48 hours from the stroke onset, patients started ELF-MF treatment, daily for 5 consecutive days. Clinical follow-up lasted 12 months. Brain MRI was performed before and 1 month after the treatment. The distribution of ELF-MF in the ischemic lesion was estimated by dosimetry. Six patients were stimulated, three for 45 min/day and three for 120 min/day. None of them reported adverse events. Clinical conditions improved in all the patients. Lesion size was reduced in one patient stimulated for 45 minutes and in all the patients stimulated for 120 minutes. Magnetic field intensity within the ischemic lesion was above 1 mT, the minimum value able to trigger a biological effect in preclinical studies. Our pilot study demonstrates that ELF-MF are safe and tolerable in acute stroke patients. A prospective, randomized, placebo-controlled, double-blind study will clarify whether ELF-MFs could represent a potential therapeutic approach
    • …
    corecore